Evidence map›Paper›PMID 27332879›Full record

ArticlePloS one2016

Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account.

Jonas Zeitz, Melike Ak, Séverine Müller-Mottet, Sylvie Scharl, Luc Biedermann, Nicolas Fournier, Pascal Frei, Valerie Pittet, Michael Scharl, Michael Fried and 3 more

2 registry-linked trialsOpen access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 89 papers.

0numbers the graph read from it
0cells of the map it votes in
89citing papers in PubMed
5.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03799471 completednot on this mapstarted 2019, after this paper: background citation

Somatosensory Profiles in Individuals With Persistent Musculoskeletal Pain and Inflammatory Bowel Disease

TypeobservationalSponsorDartmouth-Hitchcock Medical CenterRan2019 to 2019Enrolled77ConditionsInflammatory Bowel Diseases, Chronic Pain, Central Sensitization
NCT04488146 unknown statusnot on this mapstarted 2020, after this paper: background citation

Epidemiology and Characterization of Pain in Patients With Crohn Disease

TypeobservationalSponsorUniversity of LiegeRan2020 to 2021Enrolled200ConditionsCrohn Disease, Pain, Depression, Anxiety
3 · Its place in the literature

Who cites it

89 citing papers in PubMed, 148 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Electrophysiological and Proteomic Evidence of Protease-Mediated Pro-nociceptive Signaling in Inflammatory Bowel Disease Patients.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

29 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 1 country.

Jonas ZeitzDivision of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.ORCID http://orcid.org/0000-0002-0885-0064
Melike AkDivision of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Séverine Müller-MottetDivision of Pulmonology, Zurcher Rehabilitation Center Wald, Wald, Switzerland.
Sylvie ScharlDivision of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Luc BiedermannDivision of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Nicolas FournierInstitute of Social and Preventive Medicine, Université de Lausanne, Lausanne, Switzerland.
Pascal FreiGastroenterology Bethanien, Zurich, Switzerland.
Valerie PittetInstitute of Social and Preventive Medicine, Université de Lausanne, Lausanne, Switzerland.
Michael ScharlDivision of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Michael FriedDivision of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Gerhard RoglerDivision of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Stephan VavrickaDivision of Gastroenterology and Hepatology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Swiss IBD Cohort Study Group
University of Zurich · CHInstitute of Social and Preventive Medicine · CHZürcher RehaZentrum Davos · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPain is a common symptom related to inflammatory bowel disease (IBD). In addition to abdominal pain, pain can also be an extraintestinal manifestation of IBD. Pain treatment is challenging and a substantial part of IBD patients are treated with opioids. Therefore, a better knowledge on pain symptoms is crucial for a better therapeutic approach to this clinical problem.

methodsPatients of the Swiss IBD Cohort Study (SIBDCS) (n = 2152) received a questionnaire regarding pain intensity, pain localization and impact of pain on daily life and social activities. Furthermore, the questionnaire investigated the use of pain-specific medication.

resultsA vast majority of patients (71%) experienced pain during the disease course. For a substantial part of patients (49% in UC and 55% in CD) pain is a longstanding problem (>5 years). Pain in UC was of shorter duration compared to CD (p < 0.01). Abdominal pain (59.5%) and back pain (38.3%) were the main pain localizations. 67% of patients took pain medication; 24% received no pain treatment. The general quality of life was significantly lower in patients suffering of pain compared to those without pain (38 vs. 77; (-100 very bad; 100 very good) p<0.0001).

conclusionsPrevalence of pain is high in patients of the SIBDCS. It is a longstanding problem for the majority of the patients affected. Pain was found to be undertreated in the SIBDCS and was significantly associated with health-related quality of life. Thus, an increased awareness is mandatory to address this frequent complication in the course of IBD.

Indexed as

AdultFemaleHumansInflammatory Bowel DiseasesMaleMiddle AgedPainQuality of LifeTime Factors

Identifiers

PMID27332879
PMCPMC4917102
OpenAlexW2470999212

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.